SILENCE THERAPEUTICS PLC earnings per share and revenue

XRP2 earnings per share for the last quarter are -0.23 EUR whereas the estimation was -0.12 EUR which accounts for -94.38% surprise. Company revenue for the same period amounts to 1.37 M EUR despite the estimated figure of 5.26 M EUR. Estimated earnings per share for the next quarter are -0.12 EUR, and revenue is expected to reach 8.22 M EUR. Also watch annual changes over time to get a bigger picture of XRP2 earnings per share and revenue dynamics.